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Bile acids, the products of concerted host and gut bacterial metabolism, have
important signaling functions within the mammalian metabolic system and a key role
in digestion. Given the complexity of the mega-variate bacterial community residing in
the gastrointestinal tract, studying associations between individual bacterial genera and
bile acid processing remains a challenge. Here, we present a novel in vitro approach
to determine the bacterial genera associated with the metabolism of different primary
bile acids and their potential to contribute to inter-individual variation in this processing.
Anaerobic, pH-controlled batch cultures were inoculated with human fecal microbiota
and treated with individual conjugated primary bile acids (500µg/ml) to serve as the
sole substrate for 24 h. Samples were collected throughout the experiment (0, 5, 10,
and 24 h) and the bacterial composition was determined by 16S rRNA gene sequencing
and the bile acid signatures were characterized using a targeted ultra-performance liquid
chromatography-mass spectrometry (UPLC-MS) approach. Data fusion techniques were
used to identify statistical bacterial-metabolic linkages. An increase in gut bacteria
associated bile acids was observed over 24 h with variation in the rate of bile acid
metabolism across the volunteers (n = 7). Correlation analysis identified a significant
association between the Gemmiger genus and the deconjugation of glycine conjugated
bile acids while the deconjugation of taurocholic acid was associated with bacteria
from the Eubacterium and Ruminococcus genera. A positive correlation between Dorea
and deoxycholic acid production suggest a potential role for this genus in cholic
acid dehydroxylation. A slower deconjugation of taurocholic acid was observed in
individuals with a greater abundance of Parasutterella and Akkermansia. This work
demonstrates the utility of integrating compositional (metataxonomics) and functional
(metabonomics) systems biology approaches, coupled to in vitro model systems, to
study the biochemical capabilities of bacteria within complex ecosystems. Characterizing
the dynamic interactions between the gut microbiota and the bile acid pool enables a
greater understanding of how variation in the gut microbiota influences host bile acid
signatures, their associated functions and their implications for health.
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INTRODUCTION
Bile acids are a classical example of trans-genomic metabolites
arising from the combinatorial metabolism of the host genome
and the gut microbiome. Primary bile acids, cholic acid (CA)
and chenodeoxycholic acid (CDCA), are synthesized in the liver
from cholesterol and subsequently conjugated with taurine or
glycine residues, creating amphipathic molecules that are stored
in the gallbladder. Upon ingestion of a meal bile acids are
secreted from the gallbladder into the duodenum. Here, they act
as detergents emulsifying fats and reducing the luminal pH to
allow pancreatic enzymes to digest carbohydrates and proteins.
The majority of bile acids (95–99%) are reabsorbed in the
jejunum in their conjugated form and re-enter the enterohepatic
circulation (Roberts et al., 2002). The remaining 1–5% enters the
ileum and colon (∼200–800mg daily in humans) where they
are modified by the gut microbiota. Enzymes encoded in the
gut microbiome, such as bile salt hydrolases (BSH) and various
dehydroxylases, structurally modify these bile acids, increasing
the diversity of the overall pool. Firstly, BSHs cleave the amide
bond between the amino acid residue (glycine or taurine) and
their bile acid moiety. There are various different BSH enzymes
expressed across the microbiota (Jones et al., 2008) and the
full impact of BSH diversity has yet to be fully explored. One
study observed an overall reduction in bacterial BSH enzyme
diversity was associated with an increase in weight gain (Joyce
et al., 2014). Once deconjugated the steroid nucleus of the bile
acid can undergo further biotransformation. Dehydroxylases (7α
or 12α) remove hydroxyl groups from the bile acid forming
the secondary bile acids, deoxycholic acid (DCA) from CA
and lithocholic acid (LCA) from CDCA. Gut bacterial enzymes
can also modify bile acids through various other reactions
including epimerization, oxidation, and esterification. Modified
bile acids are either excreted in the feces or reabsorbed into the
enterohepatic circulation for re-processing in the liver. In the
liver, bile acids are re-conjugated with taurine or glycine or are
sulfated before secretion into the bile. These combined activities
between themicrobiota and the host result in a diverse circulating
bile acid pool.
Variation in the functionality of the microbiome across
individuals can affect these processes with downstream effects
on the composition of the bile acid pool. Functional variation
is noteworthy because bile acids have an important role in
regulating the metabolism of the host. Bile acid moieties,
arising from gut bacterial processing such as the secondary and
unconjugated primary bile acids, are functional agonists for
nuclear receptors found in the liver, heart, intestine, kidneys,
and adipose tissue (Forman et al., 1995; Parks et al., 1999;
Kim et al., 2007; Björkholm et al., 2009; Xiao et al., 2014).
The nuclear receptor farnesoid X receptor (FXR) is activated
by CDCA and to a lesser extent than CA, LCA, and DCA,
while the plasma membrane bound receptor TGR5 has a high
affinity for LCA and its conjugates (Li and Chiang, 2014). These
receptors regulate the synthesis, uptake, transportation, and
detoxification of bile acids (Chiang, 2009; Fiorucci et al., 2009) as
well as the regulation of glucose, cholesterol and triacylglyceride
concentrations in plasma and energy metabolism in muscles
(Watanabe et al., 2006; Porez et al., 2012). Secondary bile acids
can also regulate the expression of xenobiotic enzymes and
transporters in the liver, intestine, and kidney via pregnane X
receptor (PXR) and constitutive androstane receptor (CAR) (Xie
et al., 2001; Björkholm et al., 2009). Variation in the bile acid
pool may therefore also contribute to individual differences in
drug efficacy and responses. We have previously demonstrated
the importance of the microbiota in shaping the composition
and signaling potential of the bile acid pool (Swann et al.,
2011). As bile acids have detergent properties they can also
impact on gut bacterial community structure by disrupting
bacterial cell membranes, inducing DNA damage and modifying
protein structure (Kandell and Bernstein, 1991; Bernstein et al.,
1999; Begley et al., 2005; Devkota et al., 2012). The detergent
properties of the secondary bile acid DCA are 10 fold greater
than its precursor, CA (Kurdi et al., 2006) suggesting that this
bacterial modification enhances the antimicrobial activity of the
compound. Chemical exchange between gut bacteria and the
host through bile acid processing can therefore impact on host
health and modulate the community structure of the intestinal
microbiome. Characterizing the dynamic interactions between
the gut microbiota and the bile acid pool, at the genus level,
enables a greater understanding of how variation in the gut
microbiota influences host bile acid signatures, their associated
functions and their implications for health. In this study, the
bacterial processing of conjugated primary bile acids by the
human fecal microbiota has been modeled in vitro. Bacterial
profiles were determined by 16S rRNA gene sequencing analysis
and the bacterial metabolism of bile acids was studied over
time using an ultra-performance liquid chromatography-mass
spectrometry (UPLC-MS) approach.
RESULTS
Baseline Variation in the Bacterial and Bile
Acid Profiles of Human Feces
Metataxonomic analysis using the V1–V3 region of the 16S
rRNA gene provided taxonomic identification to genus level
(Figure 1B). At baseline, each donor possessed a unique fecal
bacterial profile. Alpha diversity, measured by Chao1 index
(mean 42.6, 95% confidence interval: 36.8–51.5) and inverse
Simpson diversity index (mean 7.9, 95% confidence interval: 5.4–
11.1) (Figure S2), were comparable across the vessels at baseline.
No significant differences were found in the total bacterial cell
counts using fluorescent in situ hybridization (FISH) analysis
between donors or treatments at each time point, but a reduction
in bacterial numbers (mean decrease of 0.299 log units ± 0.06)
was observed across all samples over 24 h (Figure S3).
Bile acid profiles for all seven donors were dominated by
the unconjugated primary bile acids CA and CDCA and the
unconjugated secondary bile acid DCA at baseline (Figure 1). CA
accounted for the majority of the bile acid signature for donors
1 (74.9%), 3 (41.4%), and 4 (79%) while DCA dominated the
profiles of donors 2 (63.2%), 5 (74.9%), and 7 (60.2%). Traces of
conjugated and unconjugated primary and secondary bile acids
were also detected. This included a mean abundance of GCA (4.6
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± 5.4%), GCDCA (1.5 ± 2.1%), TCDCA (0.94 ± 1.3%), TCA
(0.65 ± 0.67%), ursodeoxycholic acid (UDCA) (0.39 ± 0.77%),
glycodeoxycholic acid (GDCA) (0.09 ± 0.22%), hyodeoxycholic
acid (HDCA) (0.07± 0.09%), taurolithocholic acid (TLCA) (0.01
± 0.01%), taurodeoxycholic acid (TDCA) (0.003 ± 0.006%),
and tauroursodeoxycholic acid (TUDCA) (0.002 ± 0.003%). No
traces of glycoursodeoxycholic acid (GUDCA) or hyocholic acid
(HCA) were observed.
Characterizing the Bacterial Processing of
Primary Conjugated Bile Acids
Bile acid profiles were measured in supernatants collected over
24 h from each fecal culture using UPLC-MS and quantified
against individual bile acid standards (Figure 2). Bile acids were
metabolized by the fecal microbiota and their metabolism was
dependent upon the bile acid dosed. This bacterial processing
was immediate and even in the baseline samples (0 h), collected
shortly after the addition of the bile acid, the concentration of the
dosed bile acid was notably reduced. This was most evident in the
glycine-conjugated bile acids. For GCA, the amount measured
in the baseline sample collected immediately after the addition
of the bile acid (500µg/ml) was 194.9 ± 32.6µg/ml. At this
sampling point, CA was present at 231.7 ± 29.2µg/ml. By the
10 h sampling point, GCA was reduced to 36.5 ± 27.5µg/ml
(p = 0.0012). For GCDCA, the baseline concentration was
reduced to 332.3 ± 26µg/ml and further reduced to 8 ±
4.8µg/ml over the first 10 h (p= 0.0001). In contrast, the taurine-
conjugated bile acids were not metabolized to same extent
in the baseline samples (TCA, 409.7 ± 30.2µg/ml; TCDCA,
525.4 ± 82.3µg/ml). However, all primary conjugated bile acids
were found to be deconjugated 10 h post dosing with the TCA
and TCDCA concentrations decreasing to 53.6 ± 137.6µg/ml
(p = 0.0017) and 2.4 ± 1.2µg/ml (p < 0.0001) respectively,
over the first 10 h. The greater abundance of glycine-conjugated
bile acids in the human gut compared to those conjugated with
taurine (∼2.5–3.5 G:T ratio) may underlie these observations.
Accordingly, CA increased in the supernatants of the GCA
(231.7 ± 29.2µg/ml to 368.4 ± 29.6µg/ml; p < 0.0001)
and TCA (222.2 ± 26.9µg/ml to 358.9 ± 67.5µg/ml; p =
0.0005) supplemented vessels while CDCA increased in the
GCDCA (88.7 ± 12.4µg/ml to 123.2 ± 8.4µg/ml; p = 0.0006)
and TCDCA (72.1 ± 13.5µg/ml to 120.5 ± 7.4µg/ml; p =
0.0001) supplemented vessels over the first 10 h. A fall in CA
concentrations was observed after 10 h in the GCA and TCA
supplemented vessels. This occurred in parallel to an increase in
the dehydroxylated form of CA, the secondary bile acid DCA.
DCA concentrations rose from 68.2 ± 27.2µg/ml to 104.6 ±
40.7µg/ml (p = 0.0117) from 10 to 24 h in vessels treated
with GCA and 66.1 ± 22.5µg/ml to 93.7 ± 36.9µg/ml (p =
0.02) in those vessels supplemented with TCA (Figures 2A,B).
CDCA concentration remained consistent from 10 to 24 h but
a progressive increase in its bacterial-formed epimer, UDCA
was observed over 24 h. UDCA concentrations rose from 0.3 ±
0.3µg/ml at 0 h to 47.5 ± 40.7µg/ml at 24 h (p = 0.1362, n.s.) in
the GCDCA treated vessels and from 0.7 ± 0.7µg/ml to 35.2 ±
16µg/ml (p = 0.0781, n.s.) in the TCDCA treated vessels. It was
not possible to measure LCA, the dehydroxylated form of CDCA,
with this approach.
Illuminating the Bacterial Genera
Associated With Bile Acid Metabolism
Spearman correlation analysis between the quantified bile acid
profiles and the bacterial profiles allowed statistical linkages
between bacterial genera and bile acids to be identified at
the 10 and 24 h time points independently (Figure 3). A
dendrogramwas also constructed to indicate relatedness between
the variables. Significant associations were found between
several bacterial genera and bile acids. At 10 h the majority of
primary conjugated bile acids had been deconjugated. Positive
correlations were found at 10 h between TCA abundance and
Akkermansia (r= 0.8) and Parasutterella (r= 0.8). Bacteria from
the genus Eubacterium were negatively correlated with TCA (r
= −0.93) at this time point. CA concentrations were positively
correlated with Ruminococcus 2 (r = 0.86) at 10 h in the TCA
treated cultures. The secondary bile acid, DCA was positively
correlated with bacteria from the genus Dorea (r = 0.81) and
negatively correlated with those from the genera Parabacteroides
(r = −0.9) and Bacteroides (r = −0.8). At 24 h, there were no
statistically significant correlations in the TCA supplemented
vessels. For GCA supplemented cultures, significant correlations
were observed with CA and DCA. At 10 h, CA had positive
correlations with Gemmiger (r = 0.78), whilst DCA positively
correlated with Bacteroides (r = 0.8) and Eubacterium (r = 0.8).
At 24 h, there were negative correlations between Dorea and CA
(r = −0.8). DCA had a positive correlation with Eubacterium (r
= 0.82) and a negative correlation with Gemmiger (r =−0.85).
Significant correlations were identified between bacterial
genera and bile acids in models receiving GCDCA. The genus
Shigella (r = 0.87) was positively correlated with GCDCA
at 10 h while the genus Gemmiger (r = 0.8) was positively
correlated with CDCA at this timepoint. At 24 h, GCDCA was
strongly positively correlated with Ruminococcus 2 (r = 0.97)
while UDCA was positively correlated with Dorea (r = 0.9). In
the models supplemented with TCDCA a positive correlation
between Eubacterium (r = 0.8) and TCDCA was seen at 10 h.
This was in addition to a negative correlation between CDCA and
Akkermansia (r =−0.8) and strong correlations between UDCA
and Holdemanella (r = 1) and Veillonella (r = 1).
Inter-individual Variation in the Rate of
Bacterial Bile Acid Metabolism
Differences in the bile acidmoiety concentrations, across the time
course, infer that bile acid metabolism occurs at a unique rate
across the individual donors. A markedly reduced rate of TCA
deconjugation was seen in Donor 4 compared to the other donors
over the first 10 h (Figure 4). In this donor the concentration of
TCA remained at 402.1µg/ml at 10 h while being significantly
reduced at this time point in the remaining donors (mean 13.3
± 19.2µg/ml). Principal components analysis (PCA) was used
to assess the variance of the bacterial profiles of the donors
throughout the study (Figure S4). At 10 h the bacterial profile
of Donor 4 was notably different from the other donors with
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FIGURE 1 | Natural variation in fecal bile acid compositions and bacterial genera across healthy donors before treatment (n = 7). (A) Fecal bacterial genus abundance
was determined by Mothur analysis of the V1-V3 16S rRNA region of all fecal bacteria sequenced for each donor. (B) Fifteen bile acids moieties were quantified from
the inoculated batch culture medium using UPLC-MS.
high proportions of the bacteria from the genera; Parabacteroides,
Bacteroides, Clostridium XIVa Parasutterella and Akkermansia.
By 24 h, once TCA metabolism had begun, the bacterial profile
of Donor 4 was similar in composition to the other six donors.
A similar, albeit less pronounced, difference in deconjugation
was observed across the donors following GCA supplementation.
However, with GCA it was Donor 2 that had a slower rate
of deconjugation with 88.1µg/ml of GCA remaining at 10 h
compared to 23.5 ± 10.6µg/ml in the remaining six donors
including Donor 4 (34.6µg/ml).
To investigate the bacterial genera that influence the
deconjugation rate of TCA and GCA, correlation analyses
were performed. Baseline bacterial profiles were compared to
the concentration changes in GCA and TCA between 0 and
5 h (1GCAT5 and 1TCAT5) and 0 and 10 h (1GCAT10 and
1TCAT10) (Figure 5). Significant positive correlations were
found between the abundance of Eubacterium (r = 0.96) and
Bacteroides (r = 0.8) at baseline and TCA disappearance over the
first 5 h. Negative correlations were observed between Bacteroides
(r = −0.82) and Akkermansia abundance (r = −0.82) and TCA
deconjugation over the first 5 h suggesting that less TCA was
deconjugated in vessels containing more bacteria from these
genera. The only significant correlation with GCA disappearance
over the first 5 h was a negative association with Bacteroides (r =
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FIGURE 2 | Bile acid concentrations over 24 h following the addition of (A) glycocholic acid (GCA), (B) taurocholic acid (TCA), (C) glycochenodeoxycholic acid
(GCDCA), and (D) taurochenodeoxycholic acid (TCDCA) to human fecal batch cultures (n = 7). Values are mean expressed in µg/ml ± SD. Significant time-dependent
differences were observed in the concentrations of the individual bile acids using a one-way ANOVA. (A) ∧∧∧∧GCA p < 0.0001, ####CA p <0.0001, **** DCA p <
0.001. (B) ++++TCA p < 0.0001, ###CA p = 0.004, ****DCA p < 0.001. (C) <<<<GCDCA p < 0.0001, ////CDCA p < 0.0001. (D) >>>>TCDCA p < 0.0001,
////CDCA p < 0.0001. CA, cholic acid; DCA, deoxycholic acid; UDCA, ursodeoxycholic acid.
−0.8). No statistical associations were found for 1GCAT10 and
1TCAT10.
DISCUSSION
In this study, we demonstrate the utility of using a pH
controlled, anaerobic fecal batch culture system to model the
bacterial metabolism of individual primary conjugated bile
acids. The UPLC-MS results confirm that in an anaerobic
fecal batch culture environment, bile acids undergo the same
metabolic processes as those occurring in vivo (Frankel, 1936;
Midtvedt, 1974; Hirano et al., 1981; Fadden et al., 1997).
These observations were similar across the majority of donors
indicating a consistency in the metabolic performance of the
individual donor microbiomes. A potential limitation of this
model system is the unknown variation in bacterial succession
across the donors in the fermentation vessels. Such variation
could affect the reproducibility of the results over extended
time periods. However, over the timeframe studied here (0–
24 h), which is relevant to intestinal transit times, this variation
was not apparent. Combining this model system with an
integrated bacterial and bile acid profiling approach has enabled
specific bacterial-bile acid associations to be resolved for further
investigation. In some cases, these observations can be supported
by the genomic content of the bacteria.
Variation was observed across the bacterial and bile acid
profiles of all donors at baseline with the bile acid signatures
dominated by either unconjugated primary bile acids (CA,
CDCA) or the unconjugated secondary bile acid DCA. Greater
abundance of fecal DCA in certain donors may result from the
increased bacterial dehydroxylation of CA or reduced absorption
of this bile acid from the gut of these individuals. Alternatively,
this could reflect differences in dietary patterns across the
donors with previous studies showing that diets high in animal
fat modify the gut microbiota and increase DCA excretion
(Yatsunenko et al., 2012; David et al., 2014). High fecal excretion
of DCA has been previously linked to obesity and an increased
risk of colorectal cancer and hepatic cirrhosis (Bernstein et al.,
2005; Kakiyama et al., 2013).
Correlation analysis identified statistical linkages between 15
bacterial OTUs and individual bile acids. These belonged to the
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FIGURE 3 | Correlation matrices constructed from bile acid moieties and fecal bacterial genera at 10 and 24 h following bile acid supplementation. (A) 10 h post
taurocholic acid (TCA); (B) 10 h and (C) 24 h post glycocholic acid (GCA); (D) 10 h post taurochenodeoxycholic acid (TCDCA); (E) 10 h and (F) 24 h post
glycochenodeoxycholic acid (GCDCA) supplementation. Correlation coefficients presented as heat maps with dendrograms indicating relatedness between variables.
*Significant correlations (p < 0.05). CA, cholic acid; CDCA, chenodeoxycholic acid; DCA, deoxycholic acid; UDCA, ursodeoxycholic acid.
Bacteroidetes, Firmicutes, Proteobacteria, and Verrucomicrobia
phyla. A positive association was found between the Gemmiger
genus and CA concentration 10 h after GCA supplementation. In
this case, Gemmiger abundance increased following the cleavage
of glycine from GCA. Consistently, the Rumminococcaceae
family, within which Gemmiger resides, has been shown to
possess a bile salt hydroxylase that acts on both glycine
and taurine conjugated bile acids (Jones et al., 2008). No
associations were observed between the Gemmiger genus and
the deconjugation of tauro-conjugated bile acids however, a
number of BSH enzymes have specificity toward a single bile
acid moiety (Jones et al., 2008). Interestingly, the abundance
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FIGURE 4 | Inter-individual variation in cholate conjugated metabolism. Fifteen bile acid moiety concentrations were quantified by UPLC-MS for each donor (n = 7) at
0, 5, 10, and 24 h. The rate of taurocholic acid (TCA) and glycocholic acid (GCA) deconjugation was slower for Donor 4 and Donor 2 respectively at 10 and 24 h post
treatment with primary conjugated cholic acid moieties.
of the Gemmiger genus was negatively correlated with DCA
abundance at 24 h. DCA is cytotoxic to certain bacterial
species and can be used as an antimicrobial agent. Evidence
of these antimicrobial properties are seen with the reduction
of Clostridium difficile infections when DCA is present in
sufficient concentrations (Greathouse et al., 2015). From these
observations we speculate that bacteria from the genusGemmiger
may be susceptible to DCA toxicity and/or that it’s abundance is
dependent upon the availability of glycine-conjugated bile acids
as a substrate. Furthermore, this observation may indicate that
this species does not possess 7-α dehydroxylase, the enzyme
required to dehydroxylate the C-7 hydroxyl group of CA to
produce DCA. Further experiments are necessary to clarify these
hypotheses.
Bacterial species contained within the Lachnospiraceae cluster
were associated with several bile acids across the treatments.
The abundance of bacteria from the Eubacterium genus was
negatively correlated with TCA at 10 h (TCA-supplemented
vessels) and positively correlated with DCA at 24 h (GCA-
supplemented vessels). This link suggests that Eubacterium
abundance increases as TCA is deconjugated to CA and CA is
dehydroxylated to DCA. Consistently, members of this genus
have been shown to act as dehydroxylators (Gérard, 2013) and
possess functional BSH genes (Udayappan et al., 2016). Similarly,
the role of theRuminococcus 2 genus in the deconjugation of TCA
is inferred from the positive association to CA and is consistent
with the presence of BSH genes in the genome (Gérard,
2013). The positive associations between the Holdemanella and
Veillonella genera and UDCA at 10 h suggest these two genera
may have a role in the epimerization of CDCA, although this
observation is unique to the substrate TCDCA and genomic data
does not exist to support a causal relationship being defined.
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FIGURE 5 | Taurocholic acid deconjugation velocity is positively associated with the Eubacterium and Bacteroides genera. Correlation coefficients between the
bacterial genera present in the batch cultures at baseline and the change in TCA concentrations from 0 to 5 h (1TCAT5) and 0 to 10 h (1TCAT10) and GCA
concentrations from 0 to 5 h (1GCAT5) and 0 to 10 h (1GCAT10). Data presented as heat maps with dendograms indicating relatedness between variables.
*Significant correlations (p < 0.05).
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Inter-individual variation was observed in the rate of
TCA metabolism. Specifically, the deconjugation of TCA was
markedly retarded over the first 10 h for Donor 4 while the
remaining donors had near-complete deconjugation over this
period. The delay in taurine cleavage coincides with a lower
abundance of members from the Gemmiger, Ruminococcus 2,
Eubacterium, and Faecalibacteria genera in this donor and an
increased abundance of bacteria from the Parabacteroides genus.
Interestingly, P. distasonis has been associated with gut dysbiosis
(Dziarski et al., 2016; Jacobs et al., 2016). Correlation analysis
studying the baseline bacterial signatures with changes in the
bile acid profiles over the first 5 h revealed a positive association
between Eubacterium and Bacteroides abundance and the rate
of TCA disappearance. It is possible that the lower abundance
of Gemmiger, Ruminococcus 2, Eubacterium, and Faecalibacteria
reduces the BSH enzyme diversity in Donor 4, which may
contribute to the retardation of TCA deconjugation in this
donor. Variation in the rate of bile acid deconjugation has
downstream consequences for secondary bile acid formation
and the potential to alter gut bacterial and host metabolism
(Theisen et al., 2000; Jones et al., 2008; Bernstein et al., 2009;
Swann et al., 2011; Joyce et al., 2014). Reduced efficiency in
bile acid deconjugation could lower the rate at which CA and
thus DCA is formed in the proximal colon. Colorectal transit
time in a healthy individual is highly variable ranging from 14
to 80 h depending on age and gender (Graff et al., 2001; Haase
et al., 2016). A delay of deconjugation by 10 h could therefore
result in the greater excretion of primary bile acids, or fewer
secondary bile acids formed. Bile acids are potent detergents
and have a key role facilitating the absorption of dietary lipids,
nutrients and lipid-soluble vitamins. Deconjugation reduces the
efficiency of bile acids for the emulsification of dietary lipids
and micelle formation while CA has greater lipid-emulsification
properties than the dihydroxy bile acids, CDCA, and DCA. Such
modulations could impact on the efficiency of the enterohepatic
circulation for digesting and absorbing lipids. The downstream
effect on host metabolic signaling also needs to be considered
with the receptors FXR, PXR, CAR, and TGR5 all binding
to unconjugated or secondary bile acids to initiate signaling
cascades that influence drug and energy metabolism. Given that
these signaling pathways regulate CYP450 enzymes, alterations
in the bile acid signatures have potential to modulate the
metabolism and clearance of drugs (Kliewer and Willson,
2002; Chatterjee et al., 2005). Furthermore, a feedback loop
exists between secondary bile acid formation and gut bacterial
proliferation. For example, lower concentrations of DCA have
been linked to an increase in C. difficile infections (Greathouse
et al., 2015). The ability of the gut microbiota to deconjugate
and subsequently dehydroxylate bile acids into DCAmay protect
against C. difficile proliferation. This may be a key property in
defining the effectiveness of fecal bacterial transplants (FMT) in
the treatment of C. difficile infections and could explain the poor
efficacy of certain donors in this treatment. Hence, this rapid in
vitro approach may help to assess the efficacy of fecal bacterial
transplants prior to use.
These findings demonstrate the hypothesis-generating
potential of this approach for studying the metabolic capabilities
of complex bacterial communities. The use of 16S rRNA
gene sequencing and not full resolution metagenomics is a
limitation of the current approach. While the composition of
the bacterial communities has been investigated the functional
potential encoded in the genomes of the modeled communities
remains unknown. This prevents metabolic outcomes from
being confidently attributed to specific bacteria. Based on the
obtained results, future experiments combining metagenomic
and metabonomic approaches in this model system offer
great promise for studying metabolic functions in complex
communities and identifying the specific contributions of
individual bacteria.
CONCLUSION
Complex bacterial communities make it difficult to define
the contribution of each individual microbe to the overall
network. This work demonstrates the utility of using an in vitro
model of the human fecal microbiota, coupled with integrated
systems biology techniques, to elucidate specific bacterial-bile
acid associations against a background of complex community
interactions. Improving the resolution at which we can study
these associations is of great benefit given the importance of the
enterohepatic circulation in the regulation of host energy, lipid,
glucose, and xenobiotic metabolism.
MATERIALS AND METHODS
Closed Anaerobic Fecal Microbiota
Fermentation
Seven healthy donors, four male and three female aged 22–40
years, who did not have any history of gastrointestinal disorders
and had avoided probiotics, prebiotics, and antibiotics for at
least 3 months prior to the study, were chosen (Study design
illustrated in Figure S1). After obtaining verbal informed consent,
a standard questionnaire to collect information regarding the
health status, drugs use, clinical anamnesis, and lifestyle was
administrated before the donor was ask to provide a fecal sample.
The University of Reading ethics committee exempted this study
from review because no donors were involved in any intervention
and waived the need for written consent due to the fact the
samples received were not collected by means of intervention.
Fecal slurries were prepared by homogenizing freshly voided
human feces (10%, w/v) in phosphate-buffered saline (PBS;
0.1M, pH 7.4) using a stomacher (model 6041; Seward Scientific,
U.K.) at 460 beats/min for 120 s. Each fermentation vessel was
inoculated with 6ml of fecal slurry to 53ml of basal medium to
a final concentration of 10% v/v. All vessels set up in parallel
were inoculated with the same fecal sample. Fermentation
vessels were maintained under anaerobic conditions, at 37◦C,
by constant sparging with O2-free N2. The pH was maintained
at pH 6.7 (±0.1) by means of an automated pH controller
(Fermac 260; Electrolab, Tewkesbury, U.K.), which added 1
mol/L sodium hydroxide or hydrochloric acid as appropriate.
The basal medium contained, per liter, 2 g peptone water
(Oxoid Ltd., Basingstoke, U.K.), 2 g yeast extract (Oxoid), 0.01 g
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sodium chloride (BDH), 0.04 g dipotassium phosphate (BDH),
0.04 g, monopotassium phosphate (BDH), 0.01 g magnesium
sulfate heptahydrate (BDH), 0.01 g calcium chloride hexahydrate
(BDH), 2 g of sodium bicarbonate (BDH), 2mL Tween 80
(BDH), 0.05 g haemin (Sigma, Dorset, U.K.), 10 µL vitamin K1
(Sigma), 0.5 g cysteine-hydrochloric acid, and 1mg resazurin
(Sigma).
Five minutes after fecal inoculation, 1ml of (30 mg/ml)
primary conjugated bile acid; taurocholic acid (Sigma Aldrich);
glycocholic acid (Sigma Aldrich); taurochenodeoxycholic acid
(Sigma Aldrich); or glycochenodeoxycholic acid (Sigma Aldrich);
in PBS was added to four of the fermentation vessels to give a final
concentration of 500 µg/ ml per vessel with 1ml of PBS added to
the control fermentation vessel. Samples (3mL) were removed
at 0, 5, 10, and 24 h after incubation with the bile acid substrate.
These were prepared for analysis by UPLC-MS and 16S rRNA
sequencing.
UPLC-MS Analysis of Fecal Water Samples
Fecal water samples were analyzed using UPLC-MS as described
by Want et al. (2010). Fecal water samples were prepared
by centrifugation at 8,000 g for 10min to remove proteinous
matter from the batch culture method. The supernatant from
each sample was transferred to a fresh 1.5ml microcentrifuge
tube and stored at −80◦C until analysis. Bile acid standards
were obtained from Sigma Aldrich (Gillingham, U.K) (TUDCA,
TLCA, GDCA, GUDCA, TDCA, UDCA, GCA, LCA, TCDCA,
TCA, GCDCA, and DCA) and Steraloids Inc (London U.K)
(CDCA, CA, HDCA, and HCA). Bile acid stock solutions (1
mg/ml) were prepared in water: methanol [80:20 (v/v)] solution
and used immediately. Water, acetonitrile and methanol were
Fluka LC-MS CHROMASOLV, all obtained from Sigma Aldrich
(Gillingham, U.K). Calibration curves were created from bile
acid stocks by creating nine standards for each of the 16 bile
acid moieties as follows; 500, 250, 125, 62.5, 10, 1, 100, 10,
and 1 ng/ml. A pooled fecal water sample (QC) was prepared
by combining 10 µl of each fecal water sample from the batch
culture experiments and was injected 10 times at the start of
the run to condition the column and every 10 samples. The
purpose of the QC sample was to assess instrument stability and
to ensure consistency of peaks throughout the sample batch.
Hundred microliter of each fecal water sample was transferred
into a 350 µl volume 96 well plate. Samples were analyzed
using an Acquity UPLC system connected to a Q-TOF premier
mass spectrometer (Waters MS technologies, Ltd, Manchester,
UK). The column was a CSH C18 1.7µM (Waters) UPLC (2.1
× 100mm), the flow rate was 0.5 ml/min. The run time per
sample was 12min, 8 µl of each sample was injected with mobile
phase starting conditions of 15% acetonitrile and 85% water.
Acetonitrile concentration was increased linearly over the run
whilst water decreased, until a final solvent composition of 85%
acetonitrile and 15% water was reached. Samples were analyzed
in negative electrospray mode over a scan range of 50–1,000
m/z. Bile acids ionize strongly in negative mode, producing a
prominent [M-H]- ion and characteristic fragmentation data. MS
conditions were as follows: Capillary voltage 2.4 kV, sample cone
30V, desolvation temperature 400◦C, source temperature 120◦C,
scan duration 0.2 s, cycle time 0.22 s, and interscan delay 0.02 s.
Data were analyzed through MassLynx software (Waters
Corp.). Standard curves were constructed by least-squares linear
regression analysis using each individual bile acid moiety peak
area as calculated using the ApexTrack2 function vs. the
concentration of the standard. TargetLynx application manager
in Masslynx software (Waters Corp.) was used to generate
intensity (peak area) and concentration using the calibration
curve from the bile acid standards, for each bile acid in every
sample. Paired t-tests and one way ANOVA were performed
using GraphPad Prism 6 (GraphPad Software, Inc) andMatlab R©.
16S rRNA GENE SEQUENCING ANALYSIS
DNA Extraction
Frozen fecal water samples in 50% v/v glycerol from each culture
vessel were defrosted, centrifuged at 8,000 g for 1min and the
supernatant was removed. Glycerol was used as a preserving
agent for cell viability, while in storage at −80◦C. The cells were
washed in 1ml sterile PBS. Cells were resuspended in 0.5ml TES
buffer with the addition of 8 µl lysozyme and 2 µl mutanolysin
and incubated for 30min at 37◦C. Proteinase K (10 µl) and
RNase (10 µl) was added before incubation at 65
◦
C for 60min
and 10% SDS and further incubation at 65◦C for 15min. This
preparation was combined with 620 µl phenol/ chloroform/
water (25:24:1), the microcentrifuge tubes were inverted and
centrifuged for 10min at 1,500 g. The aqueous layer was removed
from sample, transferred to amicrocentrifuge tube and combined
with 1ml of ice cold ethanol. Samples were stored at −20◦C
overnight. Samples were centrifuged for 30min at 5,668 g, the
supernatant was removed and the DNA was left to dry before
resuspension in 50 µl H2O.
Amplification of 16S rRNA Sequence
DNA samples were amplified for sequencing using a forward
and reverse fusion primer. The forward primer was constructed
with (5′-3′) the Illumina i5 adapter (AATGATACGGCGACC
ACCGAGATCTACAC), an 8–10 bp barcode, a primer pad, and
the 28F primer (GAGTTTGATCNTGGCTCAG). The reverse
fusion primer was constructed with (5′-3′) the Illumina i7
adapter (CAAGCAGAAGACGGCATACGAGAT), an 8–10 bp
barcode, a primer pad, and the 519R primer (GTNTTACNG
CGGCKGCTG). Primer pads were designed to ensure the primer
pad/primer combination had a melting temperature of 63–66◦C.
Amplifications were performed in 25 µl reactions with Qiagen
HotStar Taq master mix (Qiagen Inc, Valencia, California), 1
µl of each 5µM primer, and 1 µl of template. Reactions were
performed on ABI Veriti thermocyclers (Applied Biosytems,
Carlsbad, California) under the following thermal profile: 95◦C
for 5min, 25 cycles of 94◦C for 30 s, 54◦C for 40 s, 72◦C
for 1min, followed by one cycle of 72◦C for 10min and 4◦C
hold.
Amplification products were visualized with eGels (Life
Technologies, Grand Island, New York). Products were pooled
equimolar and each pool was size selected in two rounds using
Agencourt AMPure XP (BeckmanCoulter, Indianapolis, Indiana)
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in a 0.7 ration for both rounds. Size selected pools were quantified
using the Quibit 2.0 fluorometer (Life Technologies) and loaded
on an Illumina MiSeq (Illumina, Inc. San Diego, California) 2 ×
300 flow cell at 10 pM.
Data Analysis
Raw sequence data from the Illumina platform was processed
using Mothur (Schloss et al., 2009) running on Linux. Using
Schloss’ SOP for MiSeq we assessed the quality of the data and,
pre-processed, assembled paired-end reads, removed chimeras,
and aligned to obtain a total number of sequences in each sample.
To analyze the bacterial communities of batch culture samples,
Mothur clustered the data according to operational taxonomic
units (OTUs), at a 97% cut-off. Singletons and any OTUs which
were not found more than 10 times in any sample were collated
into OTU_singletons and OTU_rare phylotypes, respectively, to
maintain normalization and to minimize artifacts. The shared
OTU data from Mothur (taxonomic data) was analyzed using
a combination of statistical programs R-script, stamp (Parks
and Beiko, 2010). The two methods used in this study to
compare the similarity between each sample were Jaccard’s index
of similarity and the Bray–Curtis distance measure (measure
of dissimilarity) (Lozupone and Knight, 2005; Wang et al.,
2013). Weighted Unifrac distance matrices were analyzed in
R using non-metric multidimensional scaling ordination and
the shared OTU file was used to determine the number of
times that an OTU was observed in multiple samples and for
multivariate analysis in R. OTU taxonomies (from phylum to
genus) were determined using the classifier command in Mothur
to generate the RDP taxonomy (Wang et al., 2007). A closed
reference approach was used to obtain genus level taxonomic
classifications. The OTUs identified were compared to the RDP
database of 12,681 bacterial and 531 archael 16S rRNA gene
sequences with associated taxonomy. Once this information
has been obtained the genome sequence of the genera were
studied for genes identified as either a bile salt hydrolase or
choloylglycine hydrolase. Alpha and beta indices were calculated
from these datasets with Mothur and R using the Vegan
package.
Fluorescent in Situ Hybridization
Aliquots (500 µL) of batch culture samples were fixed in ice-
cold 4% (w/v) paraformaldehyde for 4 h at 4◦C. These samples
were centrifuged at 13,000 g for 5min and washed twice in
1mL of sterile PBS. The cells were pelleted by centrifugation and
resuspended in 150 µL of sterile PBS, to which 150 µL of ethanol
was added. The samples were vortexed and stored at−20◦C until
used in hybridizations.
For the hybridizations, each sample was diluted 1 in 250 to
stop clumping of bacteria invalidating microscopy cell counts.
Twenty microliter of each sample was pipetted onto Teflon-
and poly-l-lysine-coated, six-well (10mm diameter each) slides
(Tekdon Inc., Myakka City, FL). The samples were dried onto
the slides at 46◦C for 15min and afterwards dehydrated in an
alcohol series (50, 80, and 96%, 3min each). The ethanol was
allowed to evaporate from the slides before the probes were
applied to the samples. A probe/hybridization buffer mixture
(5 µL of a 50 ng µL−1 stock of EUB338 probe plus 45 µL
of hybridization buffer) was applied to the surface of each
well. Hybridizations were performed for 4 h in an ISO20 oven
(Grant Boekel). For the washing step, slides were placed in
50mL of wash buffer containing 20 µL of 4′,6-diamidino-2-
phenylindole dihydrochloride (DAPI; 50 ng µL−1; Sigma) for
15min. They were then briefly washed (2–3 s) in ice-cold water
and dried under a stream of compressed air. Five microliters
of antifade reagent (polyvinyl alcohol mounting medium with
DABCOTM antifading; Sigma) was added to each well and a
coverslip was applied. Slides were stored in the dark at 4◦C
(for a maximum of 3 days) until cells were counted under a
Nikon E400 Eclipse microscope. DAPI slides were visualized
with the aid of a DM 400 filter and probe slides with the aid
of a DM 575 filter. Numbers of specific bacteria and DAPI-
stained entities (used to count total bacteria) were determined
using the following equation: 0.8 × ACC × 6732.42 × 50 ×
DF, where DF is the dilution factor and ACC is the average
cell count of 15 fields of view. The figure 6732.42 refers to
the area of the well divided by the area of the field of view
and the factor 50 takes the cell count back to per mL of
sample.
Data Integration
Spearman correlation analysis was performed at each sampling
point independently correlating the quantified bile acids with the
bacterial abundances across all donors. The number of bacteria
and bile acids included in the test differed across sampling points
and with the different test bile acids. Significant associations were
identified when p< 0.05.
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